Vital Therapies reported $11.51M in Current Liabilities for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Biomarin Pharmaceutical BMRN:US USD 521.02M 56.29M
Dynavax Technologies DVAX:US USD 244.08M 101.12M
Enanta Pharmaceuticals ENTA:US USD 29.83M 6.79M
Insmed INSM:US USD 137.65M 23.84M
Intercept Pharmaceuticals ICPT:US USD 221.58M 70.16M
Mirati Therapeutics MRTX:US USD 126.99M 7.84M
Omeros OMER:US USD 39.51M 1.01M
Orasure Technologies OSUR:US USD 71.7M 6.21M
Quidel QDEL:US USD 872.7M 27.3M
Regulus Therapeutics RGLS:US USD 10.52M 4.69M
Revance Therapeutics RVNC:US USD 74.73M 2.49M
Ultragenyx Pharmaceutical RARE:US USD 227.36M 6.72M
United Therapeutics UTHR:US USD 315.9M 15.6M
Vital Therapies VTL:US USD 11.51M 1.11M
Xoma XOMA:US USD 5.42M 3M